Skip to content
2000
Volume 17, Issue 4
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Cardiovascular and cerebrovascular diseases (CCVD) are a major and increasing health burden worldwide. Although treatments have been made a certain progress, the development of novel therapies for patients remains a major research object. There are a lot of drugs against CCVD, but most of them lack tissue specificity with a short half-life, which seriously limits their extensive clinical application. Utilization of some pathophysiological changes caused by CCVD, targeted drug distribution in CCVD patients could be achieved. The current review aims to capture various drug delivery systems transporting drug specifically to vascular disease, including passive, active and physicochemical targeted delivery carriers. Their design strategies and mechanisms are described in detail. The present limitations and future perspective are also discussed.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/1389450116666150416120224
2016-03-01
2025-10-12
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/1389450116666150416120224
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test